A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis

Phase 1 Not yet recruiting 24 enrolled Incyte Corporation

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is conducted to evaluate the pharmacokinetics and safety of INCB161734 in participants with impaired renal function and participants on hemodialysis.

Timeline

Start: 2026-10-26
Primary completion: 2027-03-30
Completion: 2027-03-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	INCB161734	Unknown	—	Oral

A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis

Summary

Timeline

Drugs

Indications